Guido Magni - Net Worth and Insider Trading

Guido Magni Net Worth

The estimated net worth of Guido Magni is at least $1,154 dollars as of 2024-11-10. Guido Magni is the Director of Aprea Therapeutics Inc and owns about 325 shares of Aprea Therapeutics Inc (APRE) stock worth over $1,154. Details can be seen in Guido Magni's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guido Magni has not made any transactions after 2019-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Guido Magni

To

Guido Magni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Guido Magni owns 1 companies in total, including Aprea Therapeutics Inc (APRE) .

Click here to see the complete history of Guido Magni’s form 4 insider trades.

Insider Ownership Summary of Guido Magni

Ticker Comapny Transaction Date Type of Owner
APRE Aprea Therapeutics Inc 2019-10-07 director

Guido Magni Latest Holdings Summary

Guido Magni currently owns a total of 1 stock. Guido Magni owns 325 shares of Aprea Therapeutics Inc (APRE) as of October 7, 2019, with a value of $1,154.

Latest Holdings of Guido Magni

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APRE Aprea Therapeutics Inc 2019-10-07 325 3.55 1,154

Holding Weightings of Guido Magni


Guido Magni Form 4 Trading Tracker

According to the SEC Form 4 filings, Guido Magni has made a total of 0 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years. The most-recent trade in Aprea Therapeutics Inc is the acquisition of 325 shares on October 7, 2019, which cost Guido Magni around $97,500.

Insider Trading History of Guido Magni

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Guido Magni Trading Performance

GuruFocus tracks the stock performance after each of Guido Magni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Guido Magni is 115.11%. GuruFocus also compares Guido Magni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Guido Magni within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Guido Magni's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Guido Magni

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.41 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.43 LIMIT LIMIT LIMIT LIMIT LIMIT

Guido Magni Ownership Network

Ownership Network List of Guido Magni

No Data

Ownership Network Relation of Guido Magni

Insider Network Chart

Guido Magni Owned Company Details

What does Aprea Therapeutics Inc do?

Who are the key executives at Aprea Therapeutics Inc?

Guido Magni is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .

Aprea Therapeutics Inc (APRE) Insider Trades Summary

Over the past 18 months, Guido Magni made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 26,957 shares made by Bernd R. Seizinger , and a net purchase of 23,728 shares made by Marc Duey .

In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aprea Therapeutics Inc Insider Transactions

No Available Data

Guido Magni Mailing Address

Above is the net worth, insider trading, and ownership report for Guido Magni. You might contact Guido Magni via mailing address: 700 Pennsylvania Drive, Exton Pa 19341.